Diabetes Care, Vol 23, Issue 1 34-39, Copyright © 2000 by American Diabetes Association

ARTICLES

Impaired fasting glucose: how low should it go?

JE Shaw, PZ Zimmet, AM Hodge, M de Courten, GK Dowse, P Chitson, J Tuomilehto and KG Alberti
International Diabetes Institute, Melbourne, Australia. jshotham@hotmail.com

OBJECTIVE: Impaired fasting glucose (IFG) has been recently introduced as a stage of abnormal carbohydrate metabolism, but the evidence on which its glucose limits (fasting plasma glucose [FPG] 6.1-6.9 mmol/l) are based is not strong. The aim of this study was to determine if 6.1 mmol/l represents a clear cutoff in terms of the risk of future diabetes and in terms of elevated cardiovascular risk factor levels, and to examine the use of other lower limits of IFG. RESEARCH DESIGN AND METHODS: A population-based survey of the island of Mauritius was undertaken in 1987, with a follow-up survey 5 years later. On both occasions, an oral glucose tolerance test was performed and cardiovascular risk factors were measured. RESULTS: Data were available from 4,721 nondiabetic people at baseline, and from 3,542 at follow-up. At baseline, blood pressure, lipids, and obesity increased in a linear fashion with increasing FPG, with no evidence of a threshold effect. The risk of developing hypertension at follow-up was greater for those people with baseline FPG > or =6.1 mmol/l (P<0.001). The risk of developing diabetes at follow-up increased with increasing baseline FPG, but there was little evidence of a threshold near 6.1 mmol/l. CONCLUSIONS: Cardiovascular risk and risk of future diabetes increase continually with increasing FPG, and there is no threshold value on which to base a definition of IFG. If a lower limit of approximately 5.8 mmol/l is used, the category defines a group more similar to the group with impaired glucose tolerance, with regard to total prevalence and the risk of subsequent diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi Gestational Diabetes After Delivery: Short-term management and long-term risks Diabetes Care, July 1, 2007; 30(Supplement_2): S225 - S235. [Full Text] [PDF]

				J. E. Shaw, P. Z. Zimmet, and K. G. M.M. Alberti Point: Impaired Fasting Glucose: The Case for the New American Diabetes Association Criterion Diabetes Care, May 1, 2006; 29(5): 1170 - 1172. [Full Text] [PDF]

				S. M. Haffner Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B20 - B25. [Abstract] [Full Text] [PDF]

				D. E. Williams, B. L. Cadwell, Y. J. Cheng, C. C. Cowie, E. W. Gregg, L. S. Geiss, M. M. Engelgau, K. M. V. Narayan, and G. Imperatore Prevalence of Impaired Fasting Glucose and Its Relationship With Cardiovascular Disease Risk Factors in US Adolescents, 1999-2000 Pediatrics, November 1, 2005; 116(5): 1122 - 1126. [Abstract] [Full Text] [PDF]

				A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, T. Shochat, I. Kochba, A. Rudich, and the Israeli Diabetes Research Group Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men N. Engl. J. Med., October 6, 2005; 353(14): 1454 - 1462. [Abstract] [Full Text] [PDF]

				M.-E. Piche, J.-F. Arcand-Bosse, J.-P. Despres, L. Perusse, S. Lemieux, and S. J. Weisnagel What is a Normal Glucose Value?: Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose Diabetes Care, October 1, 2004; 27(10): 2470 - 2477. [Abstract] [Full Text] [PDF]

				E. S. Tai, S. Y. Goh, J. J.M. Lee, M.-S. Wong, D. Heng, K. Hughes, S. K. Chew, J. Cutter, W. Chew, K. Gu, et al. Lowering the Criterion for Impaired Fasting Glucose: Impact on disease prevalence and associated risk of diabetes and ischemic heart disease Diabetes Care, July 1, 2004; 27(7): 1728 - 1734. [Abstract] [Full Text] [PDF]

				Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]

				Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]

				D.-J. Kim, K.-W. Kim, N.-H. Cho, J.-H. Noh, M.-S. Lee, and M.-K. Lee The Cutoff Value of Fasting Plasma Glucose to Differentiate Frequencies of Cardiovascular Risk Factors in a Korean Population Diabetes Care, December 1, 2003; 26(12): 3354 - 3356. [Full Text] [PDF]

				The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]

				I. Mogren, B. Lindahl, and U. Hogberg Impaired fasting glucose and impaired glucose tolerance are related to both heredity and low birth weight Scand J Public Health, October 1, 2003; 31(5): 382 - 388. [Abstract] [PDF]

				H. Ohnishi, S. Saitoh, S. Takagi, J.-i. Ohata, T. Isobe, Y. Kikuchi, H. Takeuchi, and K. Shimamoto Pulse Wave Velocity as an Indicator of Atherosclerosis in Impaired Fasting Glucose: The Tanno and Sobetsu Study Diabetes Care, February 1, 2003; 26(2): 437 - 440. [Abstract] [Full Text] [PDF]

				E. Barrett-Connor The oral glucose tolerance test, revisited Eur. Heart J., August 2, 2002; 23(16): 1229 - 1231. [PDF]

				H. C. Gerstein Fasting Versus Postload Glucose Levels: Why the controversy? Diabetes Care, November 1, 2001; 24(11): 1855 - 1857. [Full Text] [PDF]